138 related articles for article (PubMed ID: 2405493)
1. Status of colony-stimulating factors in cancer and AIDS.
Groopman JE
Semin Oncol; 1990 Feb; 17(1 Suppl 1):31-7; discussion 38-41. PubMed ID: 2405493
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of colony-stimulating factors.
Groopman JE
Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of recombinant human colony-stimulating factors.
Klingemann HG
CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
[TBL] [Abstract][Full Text] [Related]
4. The clinical use of colony stimulating factors.
Moore MA
Annu Rev Immunol; 1991; 9():159-91. PubMed ID: 1910675
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
Vadhan-Raj S; Keating M; LeMaistre A; Hittelman WN; McCredie K; Trujillo JM; Broxmeyer HE; Henney C; Gutterman JU
N Engl J Med; 1987 Dec; 317(25):1545-52. PubMed ID: 3500414
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395
[TBL] [Abstract][Full Text] [Related]
8. Use and toxicity of the colony-stimulating factors.
Schriber JR; Negrin RS
Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic growth factors in cancer.
Moore MA
Cancer; 1990 Feb; 65(3 Suppl):836-44. PubMed ID: 2406005
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
Fan D; O'Brian CA; Ioannides CG; Clyne RK
In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441
[TBL] [Abstract][Full Text] [Related]
11. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
12. [GM-CSF and G-CSF: cytokines in clinical application].
Ruef C; Coleman DL
Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of the myeloid growth factors.
Glaspy JA; Golde DW
Semin Hematol; 1989 Apr; 26(2 Suppl 2):14-7. PubMed ID: 2471274
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigations.
Demetri GD; Antman KH
Semin Oncol; 1992 Aug; 19(4):362-85. PubMed ID: 1509275
[TBL] [Abstract][Full Text] [Related]
15. Human recombinant derived IL-3 and GM-CSF in hematopoiesis of normal cynomolgus monkeys.
Krumwieh D; Weinmann E; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):250-7. PubMed ID: 3071338
[TBL] [Abstract][Full Text] [Related]
16. Effects of CSFs in preleukemia.
Greenberg PL; Negrin R; Nagler A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():121-6. PubMed ID: 1697191
[TBL] [Abstract][Full Text] [Related]
17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
18. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
19. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]